-
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
J Biol Chem. 1998 Apr 24;273(17):10095-8
PMID: 9553055
-
VEGF receptor signalling - in control of vascular function.
Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
PMID: 16633338
-
VEGF inhibition and renal thrombotic microangiopathy.
N Engl J Med. 2008 Mar 13;358(11):1129-36
PMID: 18337603
-
An essential role for Rac1 in endothelial cell function and vascular development.
FASEB J. 2008 Jun;22(6):1829-38
PMID: 18245172
-
Cancer and the chemokine network.
Nat Rev Cancer. 2004 Jul;4(7):540-50
PMID: 15229479
-
Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5.
Nat Cell Biol. 2008 Aug;10(8):923-34
PMID: 18604199
-
Permanent cell line expressing human factor VIII-related antigen established by hybridization.
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7
PMID: 6407019
-
Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.
J Clin Invest. 2004 Mar;113(6):885-94
PMID: 15067321
-
The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis.
Mol Cell. 2004 Apr 9;14(1):29-41
PMID: 15068801
-
Fibrosis and diseases of the eye.
J Clin Invest. 2007 Mar;117(3):576-86
PMID: 17332885
-
PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
Nat Med. 2005 Sep;11(9):933-5
PMID: 16127435
-
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.
J Cell Biol. 2004 Oct 25;167(2):223-9
PMID: 15504909
-
Mechanisms of adverse effects of anti-VEGF therapy for cancer.
Br J Cancer. 2007 Jun 18;96(12):1788-95
PMID: 17519900
-
VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.
Nat Cell Biol. 2006 Nov;8(11):1223-34
PMID: 17060906
-
Endothelial cell-cell junctions: happy together.
Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70
PMID: 15071551
-
Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo.
J Leukoc Biol. 2006 Dec;80(6):1491-9
PMID: 16997858
-
Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung.
J Clin Invest. 2006 Mar;116(3):695-702
PMID: 16485040
-
PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?
Nat Rev Drug Discov. 2006 Nov;5(11):903-18
PMID: 17080027
-
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis.
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):967-72
PMID: 17210921
-
Pathophysiological consequences of VEGF-induced vascular permeability.
Nature. 2005 Sep 22;437(7058):497-504
PMID: 16177780
-
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
Nat Med. 2005 Sep;11(9):936-43
PMID: 16127437
-
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.
Nat Med. 2003 Nov;9(11):1390-7
PMID: 14566334
-
Clinical update: new treatments for age-related macular degeneration.
Lancet. 2007 Jul 21;370(9583):204-206
PMID: 17658379
-
IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis.
J Immunol. 2003 Mar 15;170(6):3369-76
PMID: 12626597
-
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Science. 1983 Feb 25;219(4587):983-5
PMID: 6823562
-
VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.
Exp Cell Res. 2007 Sep 10;313(15):3285-97
PMID: 17686471
-
Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Thromb Haemost. 2008 Feb;99(2):279-85
PMID: 18278175
-
Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
Cancer Res. 2007 Aug 1;67(15):7358-67
PMID: 17671206
-
Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.
Mol Biol Cell. 2007 Dec;18(12):5014-23
PMID: 17928406
-
A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish.
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13990-5
PMID: 17573532
-
Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.
J Clin Invest. 2007 Nov;117(11):3421-6
PMID: 17975672
-
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.
J Clin Invest. 2008 Jun;118(6):2337-46
PMID: 18483622
-
Angiogenesis in life, disease and medicine.
Nature. 2005 Dec 15;438(7070):932-6
PMID: 16355210
-
Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19866-71
PMID: 17172449
-
CXC chemokines in angiogenesis.
J Leukoc Biol. 2000 Jul;68(1):1-8
PMID: 10914483
-
Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke.
Nat Med. 2001 Feb;7(2):222-7
PMID: 11175854
-
Phosphoinositide 3-kinases as targets for therapeutic intervention.
Curr Pharm Des. 2004;10(16):1915-22
PMID: 15180528
-
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
J Immunol. 2000 Nov 1;165(9):5269-77
PMID: 11046061
-
CXCR2--the receptor to hit?
Drug News Perspect. 2006 Dec;19(10):615-23
PMID: 17299604
-
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.
J Clin Invest. 2005 Jan;115(1):118-27
PMID: 15630451
-
Endothelium-microenvironment interactions in the developing embryo and in the adult.
Dev Cell. 2007 Feb;12(2):181-94
PMID: 17276337
-
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.
J Clin Invest. 2008 Mar;118(3):913-23
PMID: 18259607
-
Angiogenesis.
Annu Rev Med. 2006;57:1-18
PMID: 16409133
-
p21-activated kinase regulates endothelial permeability through modulation of contractility.
J Biol Chem. 2004 Nov 5;279(45):46621-30
PMID: 15333633
-
Interleukin-8 as a macrophage-derived mediator of angiogenesis.
Science. 1992 Dec 11;258(5089):1798-801
PMID: 1281554
-
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
J Leukoc Biol. 2006 Dec;80(6):1183-96
PMID: 16997855
-
Interleukin-8. A corneal factor that induces neovascularization.
Am J Pathol. 1992 Dec;141(6):1279-84
PMID: 1281615
-
Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis.
J Cell Biol. 2007 Feb 26;176(5):719-27
PMID: 17312022
-
Neutrophils promote experimental choroidal neovascularization.
Mol Vis. 2005 Jun 16;11:414-24
PMID: 15988410
-
Pegaptanib for neovascular age-related macular degeneration.
N Engl J Med. 2004 Dec 30;351(27):2805-16
PMID: 15625332
-
Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia.
Dev Cell. 2008 Jan;14(1):25-36
PMID: 18194650
-
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.
Cell. 2007 Nov 2;131(3):463-75
PMID: 17981115
-
Autocrine VEGF signaling is required for vascular homeostasis.
Cell. 2007 Aug 24;130(4):691-703
PMID: 17719546